A potential role of the heparan sulfate in the hepatitis C virus attachment

Acta Virologica

Volumn 52, Issue 1, 2008, Pages 7-15

  Heo, T H ^a  

^a Konyang University   (South Korea)

Author keywords

E2 glycoprotein; Heparan sulfate; Hepatitis C virus; Humoral immune response; Receptor

Indexed keywords

GLYCOPROTEIN E2; HEPARAN SULFATE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

CELL LINE; HEPACIVIRUS; HEPARITIN SULFATE; HEPATITIS C; HUMANS; PROTEIN BINDING; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS ATTACHMENT;

HEPATITIS C VIRUS;

EID: 44449160926     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX (1999): Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 96, 12766-12771.
2. Barth H, Schafer C, Adah MI, Zhang F, Linhardt RJ, Toyoda H, Kinoshita-Toyoda A, Toida T, Van Kuppevelt TH, Depla E, Von Weizsacker F, Blum HE, Baumert TF (2003): Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278, 41003-41012.
3. Barth H, Schnober EK, Zhang F, Linhardt RJ, Depla E, Boson B, Cosset FL, Patel AH, Blum HE, Baumert TF (2006): Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J. Virol. 80, 10579-10590.
4. Bose S, Banerjee AK (2002): Role of heparan sulfate in human parainfluenza virus type 3 infection. Virology 298, 73-83.
5. Boyle KA, Compton T (1998): Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B. J. Virol. 72, 1826-1833.
6. Capila I, Linhardt RJ (2002): Heparin-protein interactions. Angew. Chem. Int. Ed. Engl. 41, 391-412.
7. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM (1997): Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3, 866-871.
8. Chung CS, Hsiao JC, Chang YS, Chang W (1998): A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72, 1577-1585.
9. Cocquerel L, Voisset C, Dubuisson J (2006): Hepatitis C virus entry: potential receptors and their biological functions. J. Gen. Virol. 87, 1075-1084.
10. Dechecchi MC, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, Cabrini G (2001): Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 75, 8772-8780.
11. Feldman SA, Audet S, Beeler JA (2000): The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J. Virol. 74, 6442-6447.
12. Feldman SA, Hendry RM, Beeler JA (1999): Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J. Virol. 73, 6610-6617.
13. Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Abu-Ghazaleh R, Samuel A, King AM, Stuart DI (1999): The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J. 18, 543-554.
14. Gardner JP, Durso RJ, Arrigale RR, Donovan GP, Maddon PJ, Dragic T, Olson WC (2003): L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA 100, 4498-4503.
15. Garson JA, Lubach D, Passas J, Whitby K, Grant PR (1999): Suramin blocks hepatitis C binding to human hepatoma cells in vitro. J. Med. Virol. 57, 238-242.
16. Germi R, Crance JM, Garin D, Guimet J, Lortat-Jacob H, Ruigrok RW, Zarski JP, Drouet E (2002): Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J. Med. Virol. 68, 206-215.
17. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M (2001): Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75, 1565-1570.
18. Goodfellow IG, Sioofy AB, Powell RM, Evans DJ (2001): Echoviruses bind heparan sulfate at the cell surface. J. Virol. 75, 4918-4921.
19. Heo TH, Chang JH, Lee JW, Foung SK, Dubuisson J, Kang CY (2004): Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein. J. Immunol. 173, 446-455.
20. Kern A, Schmidt K, Leder C, Muller OJ, Wobus CE, Bettinger K, Von Der Lieth CW, King JA, Kleinschmidt JA (2003): Identification of a heparin-binding motif on adenoassociated virus type 2 capsids. J. Virol. 77, 11072-11081.
21. Kim CW, Goldberger OA, Gallo RL, Bernfield M (1994): Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol. Biol. Cell 5, 797-805.
22. Kroschewski H, Allison SL, Heinz FX, Mandl CW (2003): Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology 308, 92-100.
23. Lauer GM, Walker BD (2001): Hepatitis C virus infection. N. Engl. J. Med. 345, 41-52.
24. Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, Houles C, Fieschi F, Schwartz O, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R (2003): DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem. 278, 20358-20366.
25. Monazahian M, Bohme I, Bonk S, Koch A, Scholz C, Grethe S, Thomssen R (1999): Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57, 223-229.
26. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S (1998): Binding of hepatitis C virus to CD81. Science 282, 938-941.
27. Pinon JD, Klasse PJ, Jassal SR, Welson S, Weber J, Brighty DW, Sattentau QJ (2003): Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J. Virol. 77, 9922-9930.
28. Pohlmann S, Zhang J, Baribaud F, Chen Z, Leslie GJ, Lin G, Granelli-Piperno A, Doms RW, Rice CM, McKeating JA (2003): Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77, 4070-4080.
29. Reddi HV, Lipton HL (2002): Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses. J. Virol. 76, 8400-8407
30. Roderiquez G, Oravecz T, Yanagishita M, Bou-Habib DC, Mostowski H, Norcross MA (1995): Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol. 69, 2233-2239.
31. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, Weiner AJ, Lau JY, Choo QL, Chien D, Pileri P, Houghton M, Abrignani S (1996): A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc. Natl. Acad. Sci. USA 93, 1759-1763.
32. Saunier B, Triyatni M, Ulianich L, Maruvada P, Yen P, Kohn LD (2003): Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J. Virol. 77, 546-559.
33. Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, Filocamo G, Traboni C, Nicosia A, Cortese R, Vitelli A (2002): The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21, 5017-5025.
34. Seong YR, Choi S, Lim JS, Lee CH, Lee CK, Im DS (2001): Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses. Vaccine 19, 2955-2964.
35. Shukla D, Spear PG (2001): Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108, 503-510.
36. Wunschmann S, Medh JD, Klinzmann D, Schmidt WN, Stapleton JT (2000): Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J. Virol. 74, 10055-10062.
37. Yagnik AT, Lahm A, Meola A, Roccasecca RM, Ercole BB, Nicosia A, Tramontano A (2000): A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40, 355-366.
38. Yanagi M, Purcell RH, Emerson SU, Bukh J (1997): Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. USA 94, 8738-8743.